Mass balance and metabolite profiling of 14 C-Zalunfiban in humans following single-dose subcutaneous administration

XENOBIOTICA · Published 2025-12-02 · DOI 10.1080/00498254.2025.2597225

Authors being retrieved — see the publisher record. https://doi.org/10.1080/00498254.2025.2597225

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Size-dependent toxicity of microplastics and nanoplastics: insights from the Drosophila melanogaster model · XENOBIOTICA · 2026 · Same journal
Physiologically based pharmacokinetic (PBPK) modelling and simulation based integrative approach to assess natural product-drug interactions – effect of glycyrrhetinic acid on quetiapine · XENOBIOTICA · 2025 · Same journal
Lipid dysregulation in chronic diseases: systems biology and omics perspectives · XENOBIOTICA · 2026 · Same journal
Behavioural toxicodynamics and kinetic profiling of PCB congeners in Swiss Albino mouse dosed with Aroclor 1232 through inhalational route: a pivotal risk assessment study · XENOBIOTICA · 2026 · Same journal
The protective effect of linalool against carbon tetrachloride-induced testicular toxicity in rats · XENOBIOTICA · 2026 · Same journal
Steady-state pharmacokinetics of oral semaglutide using semi-mechanistic pharmacokinetic modelling and population simulations · XENOBIOTICA · 2026 · Same journal
Linalool, linalyl acetate, and lavender essential oil: evaluation of metabolism and drug interactions using canine liver microsomes and recombinant enzymes · XENOBIOTICA · 2026 · Same journal
Novel cytochrome P450 2J isoforms in tree shrews are functional drug-metabolising enzymes involved in ebastine and astemizole oxidation · XENOBIOTICA · 2026 · Same journal
Evaluation of the effects of paeoniflorin on cytochrome P450 isozymes in rats · XENOBIOTICA · 2026 · Same journal
LC-PDA & LC-MS/MS approach of Daprodustat: forced degradation study · XENOBIOTICA · 2026 · Same journal